Interpreting the hazard ratio, a higher Beclin-1 expression in adjunctively treated MCTs indicates what?

Study for the ACVIM Small Animal Internal Medicine Exam to enhance your veterinary knowledge. Prepare with flashcards and multiple-choice questions, featuring hints and explanations. Ensure success in your exam journey!

Multiple Choice

Interpreting the hazard ratio, a higher Beclin-1 expression in adjunctively treated MCTs indicates what?

Explanation:
When you interpret a hazard ratio in survival analysis, you’re looking at the relative instantaneous risk of the event occurring at any moment during follow-up. A hazard ratio greater than 1 means higher hazard in the group being studied compared to the reference group, while a hazard ratio less than 1 means lower hazard, and a value around 1 means no difference. Here, higher Beclin-1 expression in adjunctively treated mast cell tumors is associated with a hazard ratio for death that is above 1. That means patients (or tumors) with elevated Beclin-1 have a greater risk of dying at any given time point during the study than those with lower Beclin-1 expression. So the correct interpretation is that higher Beclin-1 expression indicates a higher risk of death. Beclin-1 is involved in autophagy, and its role in cancer can vary. In this context, the association with worse survival suggests that increased Beclin-1 expression may reflect mechanisms (like enhanced autophagic survival of tumor cells under treatment) that lead to poorer outcomes.

When you interpret a hazard ratio in survival analysis, you’re looking at the relative instantaneous risk of the event occurring at any moment during follow-up. A hazard ratio greater than 1 means higher hazard in the group being studied compared to the reference group, while a hazard ratio less than 1 means lower hazard, and a value around 1 means no difference.

Here, higher Beclin-1 expression in adjunctively treated mast cell tumors is associated with a hazard ratio for death that is above 1. That means patients (or tumors) with elevated Beclin-1 have a greater risk of dying at any given time point during the study than those with lower Beclin-1 expression. So the correct interpretation is that higher Beclin-1 expression indicates a higher risk of death.

Beclin-1 is involved in autophagy, and its role in cancer can vary. In this context, the association with worse survival suggests that increased Beclin-1 expression may reflect mechanisms (like enhanced autophagic survival of tumor cells under treatment) that lead to poorer outcomes.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy